Patterns of use, clinical efficacy, safety and tolerability of Ketamine and Esketamine in treatment-resistant depression: Towards registry‐based surveillance systems

More data on the long-term effects of Racemic Ketamine and Esketamine in TDR patients is needed. The implementation of centralized registries of their use for treatment of depression could be a tool of major importance for assessing their efficacy and safety in real‐world clinical practice. This pap...

Full description

Saved in:
Bibliographic Details
Published in:Journal of affective disorders 2022-01, Vol.297, p.145-147
Main Authors: López-Díaz, Álvaro, Rendón de Lope, Luisa, de la Vega Sánchez, Diego
Format: Article
Language:English
Subjects:
Antidepressive Agents - adverse effects
Depression
Depressive Disorder, Treatment-Resistant - drug therapy
Esketamine
Humans
Ketamine
Ketamine - adverse effects
Registries
Treatment Outcome
Treatment-resistant depression
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:More data on the long-term effects of Racemic Ketamine and Esketamine in TDR patients is needed. The implementation of centralized registries of their use for treatment of depression could be a tool of major importance for assessing their efficacy and safety in real‐world clinical practice. This paper seeks to outline the rise and rationale behind these registry‐based surveillance systems.
ISSN:0165-0327
1573-2517
DOI:10.1016/j.jad.2021.10.036